Overview Financials News + Filings IR Vault Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Appointed director
CC transcript
Inv. presentation
|
|
VIVUS INC (VVUS)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 11/13/2020 |
GN
| VIVUS Seeks Bankruptcy Court Approval of Second Amended Joint Chapter 11 Plan of Reorganization and Existing Stock Record Date |
| 07/07/2020 |
GN
| VIVUS Completes Solicitation for In-Court Reorganization Plan to Become a Wholly Owned Subsidiary of IEH Biopharma LLC |
| 06/02/2020 |
GN
| VIVUS Announces Updated Agreement with Icahn Enterprises Holdings L.P. |
| 05/01/2020 |
GN
| VIVUS to Host First Quarter Business Update and Financial Results Conference Call on Wednesday, May 6, 2020 |
| 05/01/2020 |
GN
| VIVUS Announces Agreement with IEH Biopharma LLC Granting the Company a 30-Day Grace Period to Restructure its Corporate Debt |
| 04/03/2020 |
GN
| VIVUS Announces Closing of $11.55 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules |
| 04/01/2020 |
GN
| VIVUS Announces $11.55 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules |
| 03/31/2020 |
GN
| VIVUS Accelerates the Launch of Telemedicine and Remote Monitoring Modules to Facilitate Effective Patient Care During “Social Distancing” |
| 02/19/2020 |
GN
| VIVUS Announces Commercial Launch of Qsymia® in the Republic of Korea Establishing New Royalty Revenue Stream |
| 02/18/2020 |
GN
| VIVUS to Host Fourth Quarter Business Update and Financial Results Conference Call on Tuesday, March 3, 2020 |
| 01/07/2020 |
GN
| New Data Further Demonstrate Effectiveness of VIVUS' Qsymia as a Weight Management Tool |
| 01/02/2020 |
GN
| VIVUS to Present at Biotech Showcase on January 13, 2020 |
| 12/31/2019 |
GN
| VIVUS Adopts Stockholder Rights Plan |
| 12/18/2019 |
GN
| VIVUS Announces New Data Supporting the Safety and Efficacy of Qsymia® in Adolescents with Obesity |
| 11/25/2019 |
GN
| VIVUS to Present at Piper Jaffray 31st Annual Healthcare Conference on December 3, 2019 |
| 11/20/2019 |
GN
| New Clinical Data Demonstrate VIVUS' Qsymia® is Effective at Reducing Binge Eating in Patients with Binge-Eating Disorder or Bulimia Nervosa |
| 10/21/2019 |
GN
| VIVUS to Highlight Integrated Approach to More Effective Weight Management in Panel Discussion at the Cleveland Clinic 2019 Medical Innovation Summit |
| 08/28/2019 |
GN
| VIVUS to Present at Upcoming Conferences |
| 08/27/2019 |
GN
| VIVUS to Share Qsymia® Safety and Efficacy Data with a Global Audience at ICOMES & AOCO 2019 |
| 08/20/2019 |
GN
| New Pilot Clinical Study Results Demonstrate that Addition of VIVUS' Qsymia® to Gastric Sleeve Surgery Significantly Improves Weight Loss Compared with Surgery Alone |
| 08/06/2019 |
GN
| VIVUS Reports Second Quarter 2019 Financial Results |
| 07/23/2019 |
GN
| VIVUS to Host Second Quarter Business Update and Financial Results Conference Call on Tuesday, August 6, 2019 |
| 06/26/2019 |
GN
| VIVUS and Nordmark Amend Contract Manufacturing Agreement to Supply Current and Future Demand for PANCREAZE® |
| 06/11/2019 |
GN
| VIVUS Reduces Barrier to Achieving Healthy Weight Goals With Launch of Online Platform to Purchase Qsymia® |
| 05/28/2019 |
GN
| VIVUS Initiates Phase Four Safety and Efficacy Study of Qsymia® in Obese Adolescents |
| 05/15/2019 |
GN
| VIVUS Partners with HarborPath Direct to Facilitate Access to PANCREAZE® for Patients Without Health Insurance |
| 04/16/2019 |
GN
| VIVUS to Host First Quarter Business Update and Financial Results Conference Call on Tuesday, April 30, 2019 |
| 02/26/2019 |
GN
| VIVUS Reports Fourth Quarter 2018 Financial Results |
| 02/13/2019 |
GN
| VIVUS to Host Fourth Quarter and Full Year Business Update and Financial Results Conference Call on Tuesday, February 26, 2019 |
| 12/27/2018 |
GN
| VIVUS to Present at Biotech Showcase on January 9, 2019 |
| 11/01/2018 |
GN
| VIVUS Reports Third Quarter 2018 Financial Results |
| 10/29/2018 |
GN
| VIVUS Adds Two New Members to the Board of Directors |
| 10/26/2018 |
GN
| VIVUS to Host Third Quarter Business Update and Financial Results Conference Call on Thursday, November 1, 2018 |
| 10/10/2018 |
GN
| VIVUS to Present at the BIO Investor Forum on October 17, 2018 |
|
|
|